Alzheimer’s disease researchers, including Duke researchers Drs. Doraiswamy and Petrella, recently published an article in Nature Medicine addressing the use of artificial intelligence (AI) in Alzheimer’s disease (AD) and related dementias research.

In the article, the writers state that AI holds significant potential to overcome major obstacles in AD research and treatment development. Despite progress, challenges like data sharing difficulties, lengthy research timelines, and the gap between lab discoveries and clinical use persist. The authors, leaders from academia, industry, and healthcare, propose that AI can revolutionize the field.

Read the full article here – https://rdcu.be/egMab

Andrieu, S., Bateman, R.J., Bereczki, E. et al. Harnessing artificial intelligence to transform Alzheimer’s disease research. Nat Med (2025). https://doi.org/10.1038/s41591-025-03632-8